0001493152-24-031378.txt : 20240812
0001493152-24-031378.hdr.sgml : 20240812
20240812172331
ACCESSION NUMBER: 0001493152-24-031378
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240809
FILED AS OF DATE: 20240812
DATE AS OF CHANGE: 20240812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mack Gene
CENTRAL INDEX KEY: 0001737979
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40237
FILM NUMBER: 241198020
MAIL ADDRESS:
STREET 1: 315 MADISON AVE
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gain Therapeutics, Inc.
CENTRAL INDEX KEY: 0001819411
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 851726310
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4800 HAMPDEN LANE
STREET 2: SUITE 200
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: (301) 500-1556
MAIL ADDRESS:
STREET 1: 4800 HAMPDEN LANE
STREET 2: SUITE 200
CITY: BETHESDA
STATE: MD
ZIP: 20814
4
1
ownership.xml
X0508
4
2024-08-09
0
0001819411
Gain Therapeutics, Inc.
GANX
0001737979
Mack Gene
C/O GAIN THERAPEUTICS, INC.
4800 MONTGOMERY LANE, SUITE 220
BETHESDA
MD
20814
0
1
0
0
CFO and Interim CEO
0
Common Stock
2024-08-09
4
P
0
14400
1.01
A
14400
D
The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.98 to $1.07 per share, inclusive. The reporting person undertakes to provide to Gain Therapeutics, Inc., any security holder of Gain Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
/s/ Gene Mack
2024-08-12